<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1794-2470</journal-id>
<journal-title><![CDATA[Nova]]></journal-title>
<abbrev-journal-title><![CDATA[Nova]]></abbrev-journal-title>
<issn>1794-2470</issn>
<publisher>
<publisher-name><![CDATA[Universidad Colegio Mayor de Cundinamarca]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1794-24702013000100003</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Lymphotherapy induce an increase of blocking factors and correct infertility problems]]></article-title>
<article-title xml:lang="es"><![CDATA[La Linfoterapia induce aumento de factores bloqueadores y corrige problemas de infertilidad]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Manrique]]></surname>
<given-names><![CDATA[Edwin]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rincón]]></surname>
<given-names><![CDATA[Verónica]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ossa]]></surname>
<given-names><![CDATA[Humberto]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidad Distrital Francisco José de Caldas  ]]></institution>
<addr-line><![CDATA[Bogotá D.C.]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Laboratory of Genetic and Molecular Biology  ]]></institution>
<addr-line><![CDATA[Bogotá D.C]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>01</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>01</month>
<year>2013</year>
</pub-date>
<volume>11</volume>
<numero>19</numero>
<fpage>25</fpage>
<lpage>31</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S1794-24702013000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S1794-24702013000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S1794-24702013000100003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[This study aimed to confirm the presence of Blocking Factors (BFs) in Mixed Lymphocyte Culture (MLC) from female normal reproducer and sub-fertile rabbit inoculated with two injection of the allogenic lymphotherapy (LIT) to analyze its effect on rate fertility and pregnancy success. The BFs measuring was done intervening MLC with MTT-Formazan non-radioactive technique. It was demonstrated BFs presence in MLC in female rabbit groups. In sub-fertile female reproducers treated with allogenic lymphotherapy a significant increase in the level of FBs after every LIT was observed, as well as a rate fertility increase. Furthermore, it was established that BFs act on cell proliferation inhibiting the MLC of other species, clearly indicating that the inhibit effect of the BFs is inter-specific and no intraspecific as had sustain until now.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Esta investigación se basó en un modelo experimental de origen animal, dirigido a comprobar la existencia de factores bloqueadores (FBs) del cultivo mixto de linfocitos (CML) en grupos de conejas reproductoras normales y subfértiles. A los animales de experimentación se les aplicó dos dosis de Linfoterapia (LIT) alogénica, con el fin de analizar sus efectos en el aumento de la tasa de fertilidad y del éxito gestacional. La medición de los FBs se realizó mediante CML con la técnica no radioactiva MTT-Formazan. Se comprobó la existencia de FBs del CML en todos los grupos de conejas estudiados. En conejas reproductoras subfértiles tratadas con LIT alogénica se observó un incremento significativo de los niveles de los FBs después de cada LIT, así como el aumento en la tasa de fertilidad de las mismas. Además, se estableció que los FBs de proliferación celular actúan inhibiendo el CML de otras especies, lo que indica claramente que el efecto inhibitorio de FBs es interespecífico y no intraespecífico como se ha sostenido hasta ahora.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[lymphotherapy]]></kwd>
<kwd lng="en"><![CDATA[blocking factors]]></kwd>
<kwd lng="en"><![CDATA[mixed lymphocytes culture]]></kwd>
<kwd lng="en"><![CDATA[subfertiles females rabbit and fetal allograft]]></kwd>
<kwd lng="es"><![CDATA[Linfoterapia]]></kwd>
<kwd lng="es"><![CDATA[factores bloqueadores]]></kwd>
<kwd lng="es"><![CDATA[cultivo mixto de linfocitos]]></kwd>
<kwd lng="es"><![CDATA[Oryctolagus cuniculus]]></kwd>
<kwd lng="es"><![CDATA[aloinjerto fetal]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[  <font face="verdana" size="2">     <p align="center"><font size="4"><b>Lymphotherapy induce an increase of blocking factors and correct  infertility problems</b></font></p>     <p align="center"><font size="3"><b>La Linfoterapia induce aumento de factores bloqueadores y corrige  problemas de infertilidad</b></font></p>       <p align="center"><i>Edwin Manrique</i><sup>1</sup>, <i>Ver&oacute;nica Rinc&oacute;n Humberto Ossa</i><sup>2</sup></p>       <p><sup>1</sup> Universidad Distrital Francisco Jos&eacute; de Caldas. Bogot&aacute;, D.C. Colombia.<br />   <sup>2</sup> Laboratory of Genetic and  Molecular Biology. Bogot&aacute;, D.C. Colombia.</p>       <p><b>Correspondence:  </b><a href="mailto:man-75@uolmail.com">man-75@uolmail.com</a> / <a href="mailto:hossa@elsitio.net.com">hossa@elsitio.net.com</a></p>       <p><b>Recibido: </b> 26/04/2013  <b>Aceptado: </b> 18/05/2013  </p>   <hr/>     <p> <b>ABSTRACT </b>    <p>This study aimed to confirm the presence of  Blocking Factors (BFs) in Mixed Lymphocyte Culture (MLC) from female normal  reproducer and sub-fertile rabbit inoculated with two injection of the  allogenic lymphotherapy (LIT) to analyze its effect on rate fertility and  pregnancy success. The BFs measuring was done intervening MLC with  MTT-Formazan non-radioactive technique.</p>      <p>It was demonstrated BFs presence in MLC in female  rabbit groups. In sub-fertile female reproducers treated with allogenic  lymphotherapy a significant increase in the level of FBs after every LIT was  observed, as well as a rate fertility increase. Furthermore, it was  established that BFs act on cell proliferation inhibiting the MLC of other  species, clearly indicating that the inhibit effect of the BFs is  inter-specific and no intraspecific as had sustain until now.</p>     ]]></body>
<body><![CDATA[<p><b>Key words:  </b>lymphotherapy,  blocking factors, mixed lymphocytes culture, subfertiles females rabbit and  fetal allograft.</p><hr/>     <p><b>RESUMEN </b></p>     <p>  Esta investigaci&oacute;n se bas&oacute; en un modelo experimental de origen animal,  dirigido a comprobar la existencia de factores bloqueadores (FBs) del cultivo  mixto de linfocitos (CML) en grupos de conejas reproductoras normales y  subf&eacute;rtiles. A los animales de experimentaci&oacute;n se les aplic&oacute; dos dosis de  Linfoterapia (LIT) alog&eacute;nica, con el fin de analizar sus efectos en el aumento  de la tasa de fertilidad y del &eacute;xito gestacional. La medici&oacute;n de los FBs  se realiz&oacute; mediante CML con la t&eacute;cnica no radioactiva MTT-Formazan. Se  comprob&oacute; la existencia de FBs del CML en todos los grupos de conejas  estudiados. En conejas reproductoras subf&eacute;rtiles tratadas con LIT alog&eacute;nica se  observ&oacute; un incremento significativo de los niveles de los FBs despu&eacute;s de  cada LIT, as&iacute; como el aumento en la tasa de fertilidad de las mismas.  Adem&aacute;s, se estableci&oacute; que los FBs de proliferaci&oacute;n celular act&uacute;an  inhibiendo el CML de otras especies, lo que indica claramente que el efecto  inhibitorio de FBs es interespec&iacute;fico y no intraespec&iacute;fico como se ha sostenido  hasta ahora.</p>     <p><b>Palabras clave:  </b>Linfoterapia, factores bloqueadores, cultivo mixto de linfocitos,  <i>Oryctolagus  cuniculus, </i> aloinjerto fetal.</p><hr/>     <p><b>INTRODUCTION </b></p>       <p>In 1994 Beer and Billingham established the bases  of the immunology of reproduction. These initial studies demonstrated that  the uterus is not a immunology privileged tissue. Furthermore, they postulated  different theories to explain the survival of fetal allograft during the  pregnancy and established the immunotherapy as treatment to recurrent  spontaneous miscarriage (1). Subsequent studies developed on animal models  allowed to understand the mechanism responsible of the fetal reabsorptions  or habitual aborts in addition to the alloinmunotherapy effects in the  reproduction (2, 3).</p>       <p> It is currently accepted that the mothers recognize  immunologically to her allogenic embryo and respond strongly to the blastocyst  implantation in endometrium. For this reason has been thought that  there are factors that regulate or suppress the immunological response  against the embryo in development, allowing to success of the  placental mammals from mammals perspective (4).</p>       <p>One of main purposes of immunology of reproduction  is establish experimental animals models to investigate the phenomenon of the  response immune maternal against the fetal allograft.  The reproductive efficiency of species for commercial utilization in  livestock field have been significantly affected for bad practices of the  genetic improvement programs that lead to high levels of endogamy. This has  generated a very low fertility rate threatening the rusticity of the  others species. The importance of this study is to evaluate the  effect of the immunotherapy as treatment for correcting specific  problems of fertility.</p>        <p><i>Blocking Factors (BFs). </i> Molecules  that prevent immune rejection of the fetal allograft during pregnancy (5,6).<br />    <i>Lymphoteraphy (LIT) or Immunotheraphy. </i> Ppurified preparation of leukocytes that is administered  intradermic. Approximately 50 million cells are inoculated from the father or  someone related to him (4).<br />    <i>FetalAllograft </i>: It has been  considered that fetus is a semi allograft due that possess 50 % of  genetic information derivate from the father. It could express antigens  from the father or its owns, which would be susceptible to immune  recognition and rejection (3).<br />    <i>Subfertile Females. </i> It have  been consider subfertile females those rabbit repeat services, meaning being  mount often and not stay pregnant. The cause of the subfertility can  aggravate immunne problems for the high level endogamics.</p>       <P><b>MATERIALS AND METHODS </b></p>        ]]></body>
<body><![CDATA[<p><i>Control group and problem group for the study.  </i>BFs in serum were quantifying from 55 female rabbits. Treatment  group consisted of 9 subfertile reproducer rabbits inoculated twice with  LIT. 8 subfertile reproducer rabbits injected twice with sterile  saline solution (SSS) denominated control group;. 20 nulliparous rabbits  (80 days) 10 normal multiparous rabbits and 8 post-parturition normal  multiparous were included. Males which have been verified its fertility  and were in active condition during time the study were utilized as  reproducers. Mononuclear cells were obtaining by puncture intracardiac  using a sterile heparinized syringe from New Zealand white (NZW) rabbits  that were going to be sacrificed. Serums from females problem and control  were drawn blood obtaining from for vein marginal puncture of the ear  into pediatrics Vacutainer tube additive-free.</p>     <p><i>Protocol for setting up of the MLC, with the  technical non-radioactive MTT-FORMAZAN. </i> NonRadioactive  cell proliferation assay is a colorimetric method to determine the viable cells  number in culture. In this assay a tetrazolium compound (3-4,5-dimetyl  thiazol-2-hl)-2,5 difenil tetrazo-lium brinide) MTT is bio-reduced by cells to  Formazan that is soluble in culture medium inside of the mitochondria.  The conversion is done by dehydrogenase enzymes found at the matrix  mitochondrial in metabolically active cells (7-9).</p>       <p>The lymphocytes were separated from whole blood by  Ficoll-Hypaque gradients (density 1,077) and centrifuge to 3000 m.p.r. for  40 minutes. With a Pasteur sterile pipette, the buffy layer was carefully  removed and transferred to another tube and 10 ml RPMI-1640 medium were  add, centrifuged for 10 minutes (2000 rpm) this procedure were done  twice. The male cells or inducers were treat with Mitomycin C 0,25 mg/ml  (for every one ml cells is utilize 0,1 ml of Mitomycin C) during  20 minutes at 37&deg;C. The cells were adjust to a final concentration of  2 x 106 cells/ml with RPMI-1640 medium adjusting the  counts in Neubauer chamber and the viability using trypan blue in microscopy  40x.</p>        <p><i>Preparation of Assay Plates. </i> 30 pl of serum from females rabbits to be tested were added to 100  pl of RPMI-1640 by triplicate. 50pl of responds cells (5000 cells/pl)  and 50 pl (5000 cells/pl) induces cells previously inactive with Mitomycin  C were added in to each well depending upon the numbers of test. The plate  was incubated at 37&deg;C for 72 hours in a humidified 5% CO2 atmosphere.</p>     <p><i>Absorbance measure and data recording. </i> 15 pl of the dye solution were added to each well and the  plate was incubated at 37&deg;C for 4 hours in humidified 5% CO2 atmosphere.  After 4 hour 100 pl of the Solubilization/Stop Solution was add to each  well.</p>           <p><b>RESULTS </b></p>     <p>BFs levels from each rabbit were measured before  and after treatment, described <a href="#t1">table 1</a> and <a href="#t2">2</a>. The proliferative response  in presence of serums (from female under study) was assessed in the MLC.</p>      <p align="center"><a name="t1"></a><img src="img/revistas/nova/v11n19/v11n19a02t01.jpg"></p>     <p align="center"><a name="t2"></a><img src="img/revistas/nova/v11n19/v11n19a02t02.jpg"></p>     <p>BFs results from control females rabbit were  obtained, mean 28,69 %, value considered as reference for normal reproducer  females without allogenic Lymphotherapy treatment. For sub-fertile  reproducer females the BFs mean was 20,79% without alloimmunotherapy  inoculation. BFs value of 38,25% were found after first alloinmunization  of sub-fertile reproducer females, after the second lymphotherapy dosage  the BFs value were 48,17% and with third dosage the values average were  55,90%. These results indicate a significant increase of the BFs  directly proportional to the number of lymphotherapy dosage. Furthermore the  lymphotherapy increased the efficiency reproductive level, in other words  success pregnancy. <a href="#t3">Table 3</a> and <a href="#t4">4</a>.</p>       ]]></body>
<body><![CDATA[<p align="center"><a name="t3"></a><img src="img/revistas/nova/v11n19/v11n19a02t03.jpg"></p>       <p align="center"><a name="t4"></a><img src="img/revistas/nova/v11n19/v11n19a02t04.jpg"></p>       <p>The average BFs for nulliparous females (80 days)  was 17.2%, normal multiparous, 30.06% and post-parturition multiparous  44.94%.<br /> It was assessed the effect of each treatment in the  number and condition of litter. Were obtained as many females treatment  with LIT as the females treatment with SSS, <a href="#t5">Table 5</a>.     <p align="center"><a name="t5"></a><img src="img/revistas/nova/v11n19/v11n19a02t05.jpg"></p>       <p>   Finally serums from 8 females of different species  were tested in human MLC to assess proliferative response. All the samples  tested inhibited the positive reaction of MLC <a href="#t6">Table 6</a></p>       <p align="center"><a name="t6"></a><img src="img/revistas/nova/v11n19/v11n19a02t06.jpg"></p>            <p><b> <i>Statistical Analysis </i> </b> </p>       <p>ANOVA analysis (randomized complete block design)  were used to evaluate the effect of lymphotherapy in the increasing of BFs in  sub-fertile reproducers females compare with sub-fertile females group  treated with salt solution. (10,11).    Using the ANOVA results significance or the  average-to-average method comparisons were carried out applying Tukey&rsquo;s  multiple comparison tests (11).</p>        <p>Statistically significant differences were found  for the group treated with lymphotherapy and highly significant between  the moment without lymphotherapy and after second lymphotherapy dosage, <a href="#t7">Table  7</a> and <a href="#f1">graphic 1.</a></p>        <p align="center"><a name="t7"></a><img src="img/revistas/nova/v11n19/v11n19a02t07.jpg"></p>        ]]></body>
<body><![CDATA[<p align="center"><a name="f1"></a><img src="img/revistas/nova/v11n19/v11n19a02f01.jpg"></p>           <p>There were no statistically significant differences  in outcome for treatment group with SSS, therefore all treatment have the same  effect, <a href="#t8">Table 8</a> and <a href="#f2">Graphic 2</a>.</p>        <p align="center"><a name="t8"></a><img src="img/revistas/nova/v11n19/v11n19a02t08.jpg"></p>           <p align="center"><a name="f2"></a><img src="img/revistas/nova/v11n19/v11n19a02f02.jpg"></p>     <p> <b>DISCUSSION </b> </p>       <p>Due to the different theories proposed to explain  the fetal allograft survival various research groups had been focus their  effort in study in depth the main role of BFs in preventing the immune  rejection of the mother against fetus. For this reason the BFs in sub-fertile reproducer  rabbit were studied. The main goal was quantify the BFs of the MLC in  animal models which could bring out new information that could being  applied in human reproduction especially in reproductive problems  with immunologic origin that cause frequent miscarriages.</p>      <p> In this study the lymphotherapy effect in the  increasing BFs levels was studied and consequently the greatest pregnancy  success chance in comparison with the SSS treatment group in t  sub-fertile reproducer rabbits.</p>      <p>   The results showed that there is a concentration  increase of BFs from MLC after each lymphocytes injection in sub-fertile  females. That supports the initial hypothesis since differences highly  significant were find between females without lymphotherapy and females after  second injection of lymphotherapy (p&gt;0.01). In contrast there  not found differences among females treated with SSS (p&lt;0.05).  Which indicate that the lymphotherapy is useful for increasing the BFs  levels and consequently correct specific cases of infertility being an  extremely useful immune therapy in case of recurrent miscarriages in  human(12-14) or other mammals. Furthermore, none harmful effect  of the lymphotherapy were observed in that species. Contrary to other  studies that sustain that lymphotherapy is not treatment that improve  the pregnancy success in women with recurrent miscarriages. These results  could be were linked to psychology hormones mediated effect (12,13).</p>       <p>The rate fertility success observed in sub-fertile  females treated with LIT was greater than the rate in females treated with  SSS. The incidence of the LIT was clear since 66% of the females got  pregnant at the second LIT injection and the outcome were the 100% at the third  injection. The BFs levels were optimal at the third LIT injection where  highly significant differences (p&gt;0.01) were observed between females  without LIT and females that received up to three LIT injections.</p>       <p>Moreover, it  was showed that the pregnancy efficiency was closely tied to good level of  BFs.      The litter size depended of a lot external  variables such as diet, stress, genetic of the animal and the weaning  which is related with the handing of production (13). The variability of the  young rabbit&rsquo;s number went from 1 at 20 per litter being a  very random data to take into account as reference of treatment with  lymphotherapy. Furthermore, note that prenatal mortality occurs usually in  all multiparous species of mammals, such as rabbits, it seems that when  there is an excessive number of morulas the normal uterine nutrients  supply is insufficient for the survival and can induce death of  considerably number of embryos, phenomenon called fetal reabsorption  (14-18). Base on the above and the study results the lymphotherapy  was associated with the fetal reabsorptions decrease which could  indicate that lymphotherapy could prevent the selection of consanguineous  embryos. at tuterus level.</p>       ]]></body>
<body><![CDATA[<p>The quantification of serums from normal females  allowed establish the FBs range levels present in normal females. To get  good success pregnancy in this specie the BFs range must fluctuate in  levels highest than 30% in average (borderline). In addition, the BFs  levels were correlated with the numbers of birth thus the more births the  higher levels of BFs were observe for the average the BFs in post-birth  females (Mean= 45%). The BFs average in nulliparous females was 17%,  suggesting that the BFs increased during the first 10 days  and maintained its high levels during the pregnancy.</p>       <p>Moreover, it was demonstrate that BFs not relate to  classical antibodies, since serum from several species used in one MLC  with the same origin inhibited the positive reaction and cell  proliferation in all cases. Thus BFs are inter-specific and not inspecific  like has been claimed in other studies.</p>      <hr>        <p><b>REFERENCES </b></p>     <!-- ref --><p> 1.    Beer A, Billingham R.E. The  embryo as a transplant. In: A Scientific American. 1974; 230: 36-46.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000056&pid=S1794-2470201300010000300001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>  2.    Maldonado J. Efecto de la aloinmunoterapia en la  reproducci&oacute;n animal. Tesis de grado como requisito parcial para optar  al t&iacute;tulo de Mag&iacute;ster en Inmunolog&iacute;a. Universidad de Antioqu&iacute;a. Facultad  de Medicina. 1993.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000058&pid=S1794-2470201300010000300002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>3.    Ossa J, S&aacute;nchez F, Cadavid A. Inmunolog&iacute;a de la  Reproducci&oacute;n. Primera Edici&oacute;n. Imprenta Universidad de  Antioqu&iacute;a. Colombia. 1993. 206 p.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000060&pid=S1794-2470201300010000300003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>4.    Ossa H, Ben&iacute;tez A, C&aacute;rdenas S, Moreno C.H.  Cuantificaci&oacute;n de factores bloqueadores del cultivo mixto de linfocitos  en mujeres abortadoras habituales tratadas con Linfoterapia. In: Medicina Reproductive. 2000; 3(1): 33-36.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000062&pid=S1794-2470201300010000300004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>     <!-- ref --><p>5.    Gurka G., Rocklin R.E.  Reproductive Immunology. In: JAMA.1987;258 (20): 2983-7.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000064&pid=S1794-2470201300010000300005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>6.    Lancet. Maternal blocking  antibodies, the fetal allograft and recurrent abortion. The Lancet. 1983.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000066&pid=S1794-2470201300010000300006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>7.    Mossmann T. Rapid colorimetric  assay for cellular growth and survival: Application to proliferation and  citotoxicity assays. In: Journal of Immunological Methods. 1983;65: 55-63.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000068&pid=S1794-2470201300010000300007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>8.    PROMEGA. 1994. CELL TITER 96 TM Aqueous  Non -Radioactive cell proliferation Assay. Technical Bulletin No 169.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000070&pid=S1794-2470201300010000300008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>     <!-- ref --><p>9.    PROMEGA. 1995. CELL TITER 96 TM Non  - Radioactive cell proliferation Assay. Technical Bulletin No 112.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000072&pid=S1794-2470201300010000300009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>     <!-- ref --><p>10.    Daniel W. Bioestad&iacute;stica. Base para el an&aacute;lisis de  ciencias de la salud. Editorial Uteha. Noriega editores. M&eacute;xico. 1997;  878p.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000074&pid=S1794-2470201300010000300010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>11.    Reyes C. 1995. Bioestad&iacute;stica Aplicada. Agronom&iacute;a,  Biolog&iacute;a, Qu&iacute;mica. Editorial Trillas. M&eacute;xico. 216p.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000076&pid=S1794-2470201300010000300011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>12.    Mowbray J, Gibbings C;  Liddell H; Reginald P; Underwood J; Beard R. Controlled trial of treatment  of recurrent spontaneous abortion by immunisation with paternal cells. The Lancet. 1985; 8435: 941-943.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000078&pid=S1794-2470201300010000300012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>13.    Ober C, Karrison T, Odem R;  Barnes R, Branch W; Stephenson M, Baron B, Ann M, Scott J, Schreiber J.  Mononuclear cell immunisation in prevention of recurrent miscarriages:  a randomised trial. The Lancet. 1999; 354: 366-369.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000080&pid=S1794-2470201300010000300013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>14.    Adams C. E. Studies on  prenatal mortality in the Rabbit, <i>Oryc-tolagus cuniculus </i>: The  amount and distribution of loss before and after implantation. In: Journal. Endocrin. 1960;19: 325-344.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000082&pid=S1794-2470201300010000300014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>15.    Adams C. E. Studies on  prenatal mortality in the Rabbit, <i>Oryc-tolagus cuniculus: </i> The  effect of transferring varying numbers of eggs. In: Journal of Endocrin. 1962; 24: 471-490.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000084&pid=S1794-2470201300010000300015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>16.    Adams C. E. Maintenance of  pregnancy relative to the presence of few embryons in the rabbit. In: Journal of Endocrin. 1970; 48:  243-249.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000086&pid=S1794-2470201300010000300016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>17.    Benitez A., Cardenas. Determinaci&oacute;n de factores  bloqueadores mediante el cultivo mixto de linfocitos (CML), t&eacute;cnica  MTT. Tesis de pregrado. Universidad Distrital Francisco Jos&eacute; de Caldas. 2000.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000088&pid=S1794-2470201300010000300017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p>      <!-- ref --><p>18.    Scott Jr, Park M, Edwin S,  Brach D. Interpretation of blocking activity in maternal serum depends on  the equation used for calculation of mixed lymphocyte culture results. In: Clinical Experimental  Immunology.1990;82: 363-368.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000090&pid=S1794-2470201300010000300018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></p> </font>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Billingham]]></surname>
<given-names><![CDATA[R.E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The embryo as a transplant]]></article-title>
<source><![CDATA[A Scientific American]]></source>
<year>1974</year>
<volume>230</volume>
<page-range>36-46</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maldonado]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Efecto de la aloinmunoterapia en la reproducción animal]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ossa]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cadavid]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Inmunología de la Reproducción]]></source>
<year>1993</year>
<edition>Primera</edition>
<page-range>206</page-range><publisher-name><![CDATA[Imprenta Universidad de Antioquía]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ossa]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Benítez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cárdenas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[C.H]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Cuantificación de factores bloqueadores del cultivo mixto de linfocitos en mujeres abortadoras habituales tratadas con Linfoterapia]]></article-title>
<source><![CDATA[Medicina Reproductive]]></source>
<year>2000</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-36</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gurka]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Rocklin]]></surname>
<given-names><![CDATA[R.E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Reproductive Immunology]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1987</year>
<volume>258</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>2983-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Lancet</collab>
<source><![CDATA[Maternal blocking antibodies, the fetal allograft and recurrent abortion]]></source>
<year>1983</year>
<publisher-name><![CDATA[The Lancet]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mossmann]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Rapid colorimetric assay for cellular growth and survival: Application to proliferation and citotoxicity assays]]></article-title>
<source><![CDATA[Journal of Immunological Methods]]></source>
<year>1983</year>
<volume>65</volume>
<page-range>55-63</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>PROMEGA</collab>
<source><![CDATA[CELL TITER 96 TM Aqueous Non -Radioactive cell proliferation Assay]]></source>
<year>1994</year>
<volume>169</volume>
<publisher-name><![CDATA[Technical Bulletin]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>PROMEGA</collab>
<source><![CDATA[CELL TITER 96 TM Non - Radioactive cell proliferation Assay]]></source>
<year>1995</year>
<volume>112</volume>
<publisher-name><![CDATA[Technical Bulletin]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Daniel]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<source><![CDATA[Bioestadística. Base para el análisis de ciencias de la salud]]></source>
<year>1997</year>
<page-range>878</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Uteha. Noriega editores]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Bioestadística Aplicada. Agronomía, Biología, Química]]></source>
<year>1995</year>
<page-range>216</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Trillas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mowbray]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbings]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Liddell]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Reginald]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Underwood]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Beard]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>1985</year>
<page-range>941-943</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ober]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Karrison]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Odem]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Branch]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Stephenson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Baron]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Schreiber]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Mononuclear cell immunisation in prevention of recurrent miscarriages: a randomised trial]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>1999</year>
<page-range>366-369</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adams C.]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Studies on prenatal mortality in the Rabbit, Oryc-tolagus cuniculus: The amount and distribution of loss before and after implantation]]></article-title>
<source><![CDATA[Journal. Endocrin]]></source>
<year>1960</year>
<volume>19</volume>
<page-range>325-344</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adams C.]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Studies on prenatal mortality in the Rabbit, Oryc-tolagus cuniculus: The effect of transferring varying numbers of eggs]]></article-title>
<source><![CDATA[Journal of Endocrin]]></source>
<year>1962</year>
<volume>24</volume>
<page-range>471-490</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adams C.]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Maintenance of pregnancy relative to the presence of few embryons in the rabbit]]></article-title>
<source><![CDATA[Journal of Endocrin]]></source>
<year>1970</year>
<volume>48</volume>
<page-range>243-249</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benitez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cardenas]]></surname>
</name>
</person-group>
<source><![CDATA[Determinación de factores bloqueadores mediante el cultivo mixto de linfocitos (CML), técnica MTT]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[Jr]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Edwin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Brach]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Interpretation of blocking activity in maternal serum depends on the equation used for calculation of mixed lymphocyte culture results]]></article-title>
<source><![CDATA[Clinical Experimental Immunology]]></source>
<year>1990</year>
<volume>82</volume>
<page-range>363-368</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
